{"id":"https://genegraph.clinicalgenome.org/r/e64115a0-7eba-4fa1-8ea0-16ca7650493av1.0","type":"EvidenceStrengthAssertion","dc:description":"TUBB2B was first reported in relation to autosomal dominant Complex cortical dysplasia with other brain malformations in 2009 (Jaglin et al., PMID: 19465910). At least 10 unique de novo missense variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 10 probands in at least 5 publications (PMIDs: 23001566, 22333901, 19465910, 26732629, 25059107). Variants in this gene segregated with disease in 2 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism for disease is dominant negative (19465910). This gene-disease relationship is supported by animal models, expression studies, and in vitro functional assays. More evidence is available in the literature, but the maximum score for experimental evidence (6 pts.) has been reached. In summary, TUBB2B is definitively associated with autosomal dominant Complex cortical dysplasia with other brain malformations. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Brain Malformations Gene Curation Expert Panel on 4/26/20 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e64115a0-7eba-4fa1-8ea0-16ca7650493a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2021-02-25T03:34:36.961Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2020-04-26T04:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5268d42b-3e52-4e12-b728-d72a6715fcd8","type":"EvidenceLine","dc:description":"This was basically an in vivo expression experiment and the mouse model was not further phenotyped.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1808459b-f67b-4461-a5c3-995f554a39c5","type":"Finding","dc:description":"Sectioning and imaging of the corpus callosum at P6 and P14 demonstrated that the variant perturbed connectivity along the cortical midline. Polymicrogyria is a disease of neuronal migration and connectivity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001566","rdfs:label":"Cedarquist_Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/24c1d0e9-591f-43c2-83c1-ee32f58c2793","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dece2fc0-883a-4974-9274-6020e1467d62","type":"Finding","dc:description":"Humans with variants in TUBB2B have polymicrogyria, a condition characterized by defective neuronal migration. When variants harbored by humans are electroporated into rats, they also show neuronal migration defects.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","rdfs:label":"Jaglin_KD Rat","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/61723260-1d2f-4150-9983-c2e90f333585","type":"EvidenceLine","dc:description":"The mouse does not survive to be able to evaluate it behaviorally to compare that with humans with variants in TUBB2B","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/054ad20d-2b05-430f-a626-0d7ef7fd8f0e","type":"Finding","dc:description":"While the homozygous mouse does not survive past birth, histology at different embryonic phases suggests defects in neurogenesisparticularly affecting the rhinencephalon, basal ganglia and the subventricular zone, which gives rise to the olfactory bulb.Our histological analysis also indicated that a number of fibertracts are affected in the brdp/brdp homozygous mutant brain. TUNEL staining in brain sections demonstrated increased neuronal cell death and reduced migration of dying neurons.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23727838","rdfs:label":"Brain dimple mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a0ebd2c-e855-40d3-b63b-da104677790c","type":"EvidenceLine","dc:description":"This experimental data was also confirmed in vitro in amniocytes isolated from the patient which demonstrated depolarization and repolarization dynamics of microtubules are deranged in cells with the p.Cys239Phe variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0112c59-8791-491f-a0e3-f36cd46d6141","type":"FunctionalAlteration","dc:description":"Flag tagged TUBB2B harboring the p.Cys239Phe (variant identified in a fetus with fetal akinesia deformation sequencing) was transfected into HeLa and COS7 cells and imaged. While it was incorporated into some forming microtubules, unlike the wild type, it was also present in diffuse staining suggesting unpolymerized tubulin heterodimers.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26732629","rdfs:label":"Laquerriere_functional alteration 1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5997679b-b1ad-4199-a6b9-ee2042c92c6a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c69fb95-0f2a-4c8f-85b6-4f23d5346a1f","type":"Finding","dc:description":"Expression of TUBB2B was measured in the developing mouse brain (by in situ hybridization and qRT-PCR) and it was demonstrated that it was highly expressed in postmitotic neurons, with dominant expression during neuronal migration and differentiation 7â€“9, and to a lesser extent in progenitor cells. RT-PCR analysis also showed that Tubb2b is expressed in astroglial cells and C6 glial cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","rdfs:label":"Expression_Jaglin","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7c7e9108-aff6-4044-9ffa-ea1c92b14760","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b23e1f6-6da5-4b99-abeb-064aed7ff8e8","type":"Finding","dc:description":"An HA and GFP-tagged TUBB2B was electroporated in utero into the callosal projection neurons at E 15.5. Sections of the brain at P6 and P14 demonstrate that TUBB2B is expressed in the corpus callosum at the cortical midline.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001566","rdfs:label":"Ceqarquist_Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46866caa-edc6-4fd6-9231-29d3b243ef5e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Tubulin dimer formation was measured after transcription and translation with a rabbit reticulocyte lysate assay and the L228P variant causes markedly reduced heterodimer formation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8049443-3e4d-445e-8d7a-c734ba349561","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","rdfs:label":"P2 Male","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"detectionMethod":"Full sequencing of TUBB2B","phenotypeFreeText":"Severe neuromotor impairment (tetraplegia), sits with aid, unskillful manipulation/no visual contact, Infantile spasms (3 months), polymicrogyria Predominant in frontal and temporal lobes (including the hippocampus)","previousTesting":true,"previousTestingDescription":"Microarray, DCX (RefSeq NM_181807), LIS1 (RefSeq NM_000430), ARX\n(RefSeq NM_139058), TUBA1A (RefSeq NM_006009), and GPR56 (RefSeq\nNM_201524)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/46866caa-edc6-4fd6-9231-29d3b243ef5e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","allele":{"id":"https://genegraph.clinicalgenome.org/r/c194166b-c4a8-4db7-bfdc-4504ce5b7be6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.683T>C (p.Leu228Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA250425"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/0cf0e8c6-ecd9-4f3f-bdd5-4772b59de233_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37d1e0cd-d19c-4ecb-869c-e4b753ffabe4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22333901","rdfs:label":"Patient 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"detectionMethod":"Sequencing of the entire TUBB2B gene","phenotypeFreeText":"Brain MRI, performed at 6 months, revealed pachygyria with cortical thickening and irregular folding in the post-rolandic and parieto-posterior temporal regions, microcephaly, postural delay, nonverbal","previousTesting":true,"previousTestingDescription":"Negative genetic testing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0cf0e8c6-ecd9-4f3f-bdd5-4772b59de233_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22333901","allele":{"id":"https://genegraph.clinicalgenome.org/r/adb4f022-5905-430d-a2f6-e8015c2727b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.767A>G (p.Asn256Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA250740"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8792b9d8-82b5-443e-8f3e-7e1503185dbf_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa11dcbb-601d-49d7-93fd-53e7a343a6e9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","rdfs:label":"P4 Male","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"detectionMethod":"Sequencing of the entire Tubb2b gene","phenotypeFreeText":"Severe neuromotor impairment (tetraparesis); walks with aid, unskillful manipulation/limited\nlanguage, generalized seizures, Polymicrogyria (Asymmetrical, predominant\nin left frontal, parietal and temporal lobes)","previousTesting":true,"previousTestingDescription":"Microarray, DCX (RefSeq NM_181807), LIS1 (RefSeq NM_000430), ARX (RefSeq NM_139058), TUBA1A (RefSeq NM_006009), and GPR56 (RefSeq NM_201524)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8792b9d8-82b5-443e-8f3e-7e1503185dbf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","allele":{"id":"https://genegraph.clinicalgenome.org/r/f3e1ea8f-5538-489a-bdc0-ff899a640f78","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.629T>C (p.Ile210Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362587639"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9d9882bc-85e0-48b6-aa9d-efbcf4c880cf_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Tubulin dimer formation was measured after transcription and translation with a rabbit reticulocyte lysate assay and the F265L variant causes markedly reduced heterodimer formation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0fc525ba-6ae3-464e-9842-fc805069d94e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","rdfs:label":"P3 Male","ageType":"AgeAtReport","ageUnit":"Years","ageValue":37,"detectionMethod":"Sequencing of Tubb2b","phenotypeFreeText":"severe mental retardation, generalized occasional seizures, Polymicrogyria Asymmetrical, predominant in left frontal, parietal and temporal lobes (including the hippocampus)","previousTesting":true,"previousTestingDescription":"Microarray, DCX (RefSeq NM_181807), LIS1 (RefSeq NM_000430), ARX (RefSeq NM_139058), TUBA1A (RefSeq NM_006009), and GPR56 (RefSeq NM_201524)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9d9882bc-85e0-48b6-aa9d-efbcf4c880cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2deb796-052d-4589-a868-fc267dd1a533","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.793T>C (p.Phe265Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA250426"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/453dce6d-7127-4f42-848a-021d282c8b51_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Electroporating TUBB2B constructs with the p.T312M variant into the KD rat cortexes does not rescue the migration defect caused by TUBB2B knockdown.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e7902d7-e8fc-4425-8a4f-4b217b0e7f9e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","rdfs:label":"P1 Male","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"detectionMethod":"TUBB2B was sequenced directly.","phenotypeFreeText":"Severe neuromotor impairment (tetraparesis); walks with aid, unskillful manipulation/limited\nlanguage, Polymicrogyria (Predominant in left frontal and parietal lobes)","previousTesting":true,"previousTestingDescription":"Microarray, DCX (RefSeq NM_181807), LIS1 (RefSeq NM_000430), ARX\n(RefSeq NM_139058), TUBA1A (RefSeq NM_006009), and GPR56 (RefSeq\nNM_201524).","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/453dce6d-7127-4f42-848a-021d282c8b51_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","allele":{"id":"https://genegraph.clinicalgenome.org/r/546d5537-95d1-4e11-8b67-b234236d63c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.935C>T (p.Thr312Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362586376"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/f168af5e-09a0-4fa4-8d94-8366a78f2579_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Electroporating TUBB2B constructs with the p.S182P variant into the KD rat cortexes does not rescue the migration defect caused by TUBB2B knockdown. The variant also failed for form functional microtubules.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7999b9bc-abc1-4bea-b56a-02ec88840e82","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","rdfs:label":"Male fetus","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":27,"detectionMethod":"sequencing of entire TUBB2B gene","phenotypeFreeText":"Polymicrogyria (Bilateral and asymmetrical, frontotemporal)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f168af5e-09a0-4fa4-8d94-8366a78f2579_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19465910","allele":{"id":"https://genegraph.clinicalgenome.org/r/4147bf94-7665-4f21-841d-c5810dfb4e88","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.514T>C (p.Ser172Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA250424"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/3c2ef240-15ec-4d77-9e02-6ce96575e366_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9abc097-5b80-4c51-ab80-267862c852a9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22333901","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"detectionMethod":"Sequencing of entire TUBB2B gene","phenotypeFreeText":"delayed development (sitting, walking, and language), microcephaly, tonic seizures in sleep began at 11 months, diffuse polymicrogryria in the perisylvian regions, small pons","previousTesting":true,"previousTestingDescription":"Negative genetic testing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3c2ef240-15ec-4d77-9e02-6ce96575e366_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22333901","allele":{"id":"https://genegraph.clinicalgenome.org/r/1897ef4d-36d7-4ce8-bf84-5e67724528ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.1249G>A (p.Asp417Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA250738"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a884bc1-01df-4213-af30-a2ef5bffc9d5_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bca72b4-0eef-4ffa-83d2-e8d4f1f3199b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001566","rdfs:label":"1:2, mother","ageType":"AgeAtReport","ageUnit":"Years","ageValue":44,"detectionMethod":"Linkage analysis was previously performed and then the \"disease gene\" from the linkage region (KIF1A and TUBB2B) were both sequenced. No variants were found and then some candidate genes from the linkage region were sequenced (TUBB1A and TUBB2B)","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Congenital fibrosis of the extraocular muscles, intellectual disability, polymicrogyria, bilaterial ptosis, microcephaly","previousTesting":true,"previousTestingDescription":"Haplotype analysis was done in the mother and two affected daughters.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9a884bc1-01df-4213-af30-a2ef5bffc9d5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001566","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e1b43dd-e945-4c78-bf34-8fe0e1295442","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.1261G>A (p.Glu421Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345331"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c0f46a68-7928-45d1-8936-999a3e86db6a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Only the mother was available for testing and she did not harbor the variant, but it cannot be confirmed that the variant is truly de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13dcfb1a-e569-4888-b831-ed3f49d37c61","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22333901","rdfs:label":"Patient 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"detectionMethod":"Sequencing of the entire TUBB2B gene","phenotypeFreeText":"At the age of 10 years, neurological examination revealed microcephaly, moderate mental retardation, oromotor dyspraxia and sialorrhea. EEG was unremarkable. Brain MRI revealed\ndiffuse polymicrogyria with a remarkably irregular cortical surface, reminiscent of the cobblestone cortex. There was a minor cavum septi pellucidi. The corpus callosum and cerebellum were normal.","previousTesting":true,"previousTestingDescription":"Negative genetic testing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c0f46a68-7928-45d1-8936-999a3e86db6a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22333901","allele":{"id":"https://genegraph.clinicalgenome.org/r/1619a007-66e9-467e-9c5c-339862573ad1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178012.5(TUBB2B):c.350T>C (p.Leu117Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA250742"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/81ced164-4ef1-4256-a727-84e79930efcc_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01e64d09-ede5-49e6-8456-b9e5c2a09a71_proband_segregation","type":"FamilyCosegregation","dc:description":"This family is too small to score for a dominant curation. Only families with 4 or more segregations are included.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23001566","rdfs:label":"Cedarquist_Family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/01e64d09-ede5-49e6-8456-b9e5c2a09a71","type":"Family","rdfs:label":"Cedarquist_Family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0bca72b4-0eef-4ffa-83d2-e8d4f1f3199b"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Congenital fibrosis of the extraocular muscles, intellectual disability, polymicrogyria, bilaterial ptosis, microcephaly","phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/0bca72b4-0eef-4ffa-83d2-e8d4f1f3199b"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":2053,"specifiedBy":"GeneValidityCriteria7","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/xusiIjizwWI","type":"GeneValidityProposition","disease":"obo:MONDO_0000904","gene":"hgnc:30829","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_81ced164-4ef1-4256-a727-84e79930efcc-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}